INCY
Incyte Corporation
Latest News for INCY
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Revolution Medicines (RVMD – Research Report), Roche Holding AG (......
Analysts fell to the sidelines weighing in on Outset Medical (OM – Research Report) and Incyte (INCY – Research Report) with neutral ratings, indic......
Incyte ($INCY) announced an update on their ongoing clinical study. Incyte’s latest clinical update centers on a Phase 0 observational study titled......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Incyte (INCY – Research Report), SI-Bone (SIBN – R......
Incyte ($INCY) announced an update on their ongoing clinical study. Incyte’s Povorcitinib Trial Marks Progress in Treating Painful Skin Disorder HS......
Exchange-traded funds (ETFs) offer a huge—and often confusing—number of choices. TipRanks’ ETF AI Analyst narrows it down to three ETFs with Outper......
Incyte ($INCY) announced an update on their ongoing clinical study. Incyte Clinical Study Sheds Light on New Drug’s Early Safety Profile The study,......
In a report released yesterday, Derek Archila from Wells Fargo maintained a Buy rating on Incyte, with a price target of $116.00. The company’s sha......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Argenx Se (ARGX – Research Report) and Incyte (INC......
BMO Capital analyst Evan Seigerman maintained a Sell rating on Incyte on January 2 and set a price target of $75.00. The company’s shares closed ye......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 12 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INCY | $101.18 | -1.5% | 857.33K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |